Apyx Medical Statistics
Total Valuation
Apyx Medical has a market cap or net worth of $41.76 million. The enterprise value is $49.67 million.
Important Dates
The last earnings date was Thursday, May 8, 2025, before market open.
| Earnings Date | May 8, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Apyx Medical has 37.79 million shares outstanding. The number of shares has increased by 7.72% in one year.
| Current Share Class | 37.79M |
| Shares Outstanding | 37.79M |
| Shares Change (YoY) | +7.72% |
| Shares Change (QoQ) | +8.60% |
| Owned by Insiders (%) | 14.56% |
| Owned by Institutions (%) | 24.94% |
| Float | 29.12M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.87 |
| Forward PS | 0.86 |
| PB Ratio | 3.97 |
| P/TBV Ratio | 3.97 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.05 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.45, with a Debt / Equity ratio of 3.66.
| Current Ratio | 5.45 |
| Quick Ratio | 4.49 |
| Debt / Equity | 3.66 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -2.60 |
Financial Efficiency
Return on equity (ROE) is -129.51% and return on invested capital (ROIC) is -17.58%.
| Return on Equity (ROE) | -129.51% |
| Return on Assets (ROA) | -14.60% |
| Return on Invested Capital (ROIC) | -17.58% |
| Return on Capital Employed (ROCE) | -30.17% |
| Revenue Per Employee | $214,945 |
| Profits Per Employee | -$91,077 |
| Employee Count | 220 |
| Asset Turnover | 0.72 |
| Inventory Turnover | 2.08 |
Taxes
In the past 12 months, Apyx Medical has paid $248,000 in taxes.
| Income Tax | 248,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -28.00% in the last 52 weeks. The beta is 1.12, so Apyx Medical's price volatility has been higher than the market average.
| Beta (5Y) | 1.12 |
| 52-Week Price Change | -28.00% |
| 50-Day Moving Average | 1.10 |
| 200-Day Moving Average | 1.30 |
| Relative Strength Index (RSI) | 51.06 |
| Average Volume (20 Days) | 54,108 |
Short Selling Information
The latest short interest is 258,778, so 0.68% of the outstanding shares have been sold short.
| Short Interest | 258,778 |
| Short Previous Month | 247,289 |
| Short % of Shares Out | 0.68% |
| Short % of Float | 0.89% |
| Short Ratio (days to cover) | 3.60 |
Income Statement
In the last 12 months, Apyx Medical had revenue of $47.29 million and -$20.04 million in losses. Loss per share was -$0.54.
| Revenue | 47.29M |
| Gross Profit | 29.08M |
| Operating Income | -15.28M |
| Pretax Income | -28.50M |
| Net Income | -20.04M |
| EBITDA | -14.69M |
| EBIT | -15.28M |
| Loss Per Share | -$0.54 |
Full Income StatementBalance Sheet
The company has $31.01 million in cash and $38.92 million in debt, giving a net cash position of -$7.91 million or -$0.21 per share.
| Cash & Cash Equivalents | 31.01M |
| Total Debt | 38.92M |
| Net Cash | -7.91M |
| Net Cash Per Share | -$0.21 |
| Equity (Book Value) | 10.64M |
| Book Value Per Share | 0.28 |
| Working Capital | 42.34M |
Full Balance SheetCash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Full Cash Flow StatementMargins
Gross margin is 61.49%, with operating and profit margins of -32.31% and -42.37%.
| Gross Margin | 61.49% |
| Operating Margin | -32.31% |
| Pretax Margin | -42.07% |
| Profit Margin | -42.37% |
| EBITDA Margin | -31.06% |
| EBIT Margin | -32.31% |
| FCF Margin | n/a |